Financial Management Professionals’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Financial Management Professionals's REGN Position: Q2 2026 in Review
Financial Management Professionals reduced its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, selling an estimated $7.49K and leaving 18 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #562.
Financial Management Professionals first reported a position in REGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $114K in Q1 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Financial Management Professionals held 18 shares of Regeneron Pharmaceuticals worth $11.2K as of Q2 2026.
- Financial Management Professionals sold 11 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.49K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #562 holding.
- Financial Management Professionals first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
- Financial Management Professionals's Regeneron Pharmaceuticals position peaked at $114K in Q1 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.